SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 362 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $93 | -94.8% | 811 | -93.8% | 0.02% | -97.1% |
| Q1 2023 | $1,792 | -99.9% | 13,000 | -48.0% | 0.77% | -20.1% |
| Q4 2021 | $2,251,000 | +15.8% | 25,000 | 0.0% | 0.96% | +153.7% |
| Q2 2021 | $1,944,000 | +30.4% | 25,000 | +25.0% | 0.38% | -30.1% |
| Q1 2021 | $1,491,000 | -48.6% | 20,000 | -11.1% | 0.54% | -49.5% |
| Q4 2019 | $2,903,000 | +156.9% | 22,500 | +50.0% | 1.08% | +89.1% |
| Q3 2019 | $1,130,000 | -73.0% | 15,000 | -45.5% | 0.57% | -43.6% |
| Q2 2019 | $4,179,000 | +133.7% | 27,500 | +83.3% | 1.01% | +53.4% |
| Q1 2019 | $1,788,000 | -18.1% | 15,000 | -25.0% | 0.66% | -44.0% |
| Q4 2018 | $2,183,000 | -45.9% | 20,000 | -20.0% | 1.18% | -18.3% |
| Q3 2018 | $4,038,000 | +1.8% | 25,000 | -16.7% | 1.44% | -5.5% |
| Q2 2018 | $3,965,000 | +78.4% | 30,000 | 0.0% | 1.52% | +47.1% |
| Q1 2018 | $2,223,000 | +33.2% | 30,000 | 0.0% | 1.04% | +67.5% |
| Q4 2017 | $1,669,000 | – | 30,000 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |